Abstract
EP1572 (JMV1843 [Aib-DTrp-DgTrp-CHO]) is a new peptido-mimetic GH secretagogue (GHS) showing binding potency to the GHS-receptor in animal and human tissues similar to that of ghrelin and peptidyl GHS. EP1572 induces marked GH increase after sc administration in neonatal rats. Preliminary data in 2 normal young men show that: 1) acute iv EP1572 administration (1.0 μg/kg) induces strong and selective increase of GH levels; 2) single oral EP1572 administration strongly and reproducibly increases GH levels even after a dose as low as 0.06 mg/kg. Thus, EP1572 is a new peptido-mimetic GHS with potent and selective GH-releasing activity.
| Original language | English |
|---|---|
| Pages (from-to) | RC26-RC28 |
| Journal | Journal of Endocrinological Investigation |
| Volume | 25 |
| Issue number | 8 |
| DOIs | |
| Publication status | Published - Sept 2002 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- GH
- Ghrelin receptors
- Humans
- Oral administration
- Synthetic GH secretagogues
Fingerprint
Dive into the research topics of 'EP1572: A novel peptido-mimetic GH secretagogue with potent and selective GH-releasing activity in man'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver